Literature DB >> 9613784

Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients.

M Machetti1, M Feasi, N Mordini, M T Van Lint, A Bacigalupo, J P Latgé, J Sarfati, C Viscoli.   

Abstract

The performance of two Aspergillus antigenemia systems, the sandwich enzyme-linked immunosorbent assay (ELISA), Platelia Aspergillus test, and the latex agglutination (LA), Pastorex Aspergillus test, in the diagnosis of invasive aspergillosis were compared by testing 364 serum samples from 22 bone marrow transplant (BMT) recipients. Sensitivity and specificity for the ELISA test were 60% and 82% respectively, vs 40% and 94% for the LA test. In the two patients found positive with both methods, the ELISA test became positive earlier than the LA test or remained positive after the LA test had become negative. These results encourage further evaluation of the Platelia Aspergillus test, to assess its role in the management of invasive aspergillosis in BMT patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613784     DOI: 10.1038/sj.bmt.1701206

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  17 in total

Review 1.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

2.  Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period.

Authors:  Daniel C Zedek; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  [Serological tests for diagnosing fungal infections].

Authors:  Cornelia Lass-Flörl
Journal:  Wien Med Wochenschr       Date:  2007

4.  Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments.

Authors:  Emmanuelle Bart-Delabesse; Maria Basile; Ahmad Al Jijakli; Didier Souville; Frédérick Gay; Bruno Philippe; Philippe Bossi; Martin Danis; Jean-Paul Vernant; Annick Datry
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Reproducibility of low galactomannan enzyme immunoassay index values tested in multiple laboratories.

Authors:  Arlo Upton; Anja Gugel; Wendy Leisenring; Ajit Limaye; Barbara Alexander; Randall Hayden; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 6.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

7.  Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.

Authors:  Alban Aubry; Raphael Porcher; Julie Bottero; Sophie Touratier; Thierry Leblanc; Benoît Brethon; Philippe Rousselot; Emmanuel Raffoux; Jean Menotti; Francis Derouin; Patricia Ribaud; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

8.  Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis.

Authors:  Claudio Viscoli; Marco Machetti; Paola Gazzola; Andrea De Maria; Dimitri Paola; Maria Teresa Van Lint; Francesca Gualandi; Mauro Truini; Andrea Bacigalupo
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 9.  Current status of nonculture methods for diagnosis of invasive fungal infections.

Authors:  Siew Fah Yeo; Brian Wong
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  A comparison of galactomannan-ELISA and a newly developed galactomannan-LATEX test in the serologic diagnosis of invasive aspergillosis in patients with hematologic malignancies.

Authors:  X Keutgen; R Hachem; Y Jiang; T Pham-Williams; J Tarrand; I Raad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-07-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.